L3VLUP
ProSign in

DNA in the 13F filings

Ginkgo Bioworks Holdings Inc · CUSIP 37611X209

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Quarter end
30 Jun 2026
the date the book describes
Filed
2 Sep 2026
latest of these filings; the earliest 3 Aug 2026
Managers listing it
23
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q1 2026 and Q2 2026; 2 listed it in both
Shares listed
9,512,168
combined, among listed positions
Reported value
$94m
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 11 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,276,011.

Managers listing DNA in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

23 of 23 holders

ActionFiling
Viking Global Investors LP3,577,128$35m0.10%Held014 Aug 2026 (the filing on sec.gov)
Baillie Gifford & Co2,391,649$24munder 0.1%Held06 Aug 2026 (the filing on sec.gov)
Millennium Management LLC638,676$6.3munder 0.1%Added+150,71914 Aug 2026 (the filing on sec.gov)
AQR Capital Management LLC621,625$6.2munder 0.1%Added+326,83714 Aug 2026 (the filing on sec.gov)
Renaissance Technologies LLC539,856$5.3munder 0.1%Added+439,40013 Aug 2026 (the filing on sec.gov)
Tudor Investment Corp335,710$3.3munder 0.1%Trimmed-128,95314 Aug 2026 (the filing on sec.gov)
Acadian Asset Management LLC289,273$2.9munder 0.1%Added+243,10213 Aug 2026 (the filing on sec.gov)
Invesco Ltd211,723$2.1munder 0.1%Trimmed-23,08514 Aug 2026 (the filing on sec.gov)
Caxton Associates LLP154,647$1.5munder 0.1%Added+85,86914 Aug 2026 (the filing on sec.gov)
D. E. Shaw & Co.151,356$1.5munder 0.1%Added+124,18714 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC130,935$1.3munder 0.1%Newnew2 Sep 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc93,528$927kunder 0.1%Trimmed-8,78314 Aug 2026 (the filing on sec.gov)
Marshall Wace LLP77,937$772kunder 0.1%Newnew13 Aug 2026 (the filing on sec.gov)
Two Sigma Investments LP60,454$599kunder 0.1%Trimmed-3,16214 Aug 2026 (the filing on sec.gov)
MFS Investment Management47,090$467kunder 0.1%Trimmed-1,8773 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP39,372$390kunder 0.1%Trimmed-16,86414 Aug 2026 (the filing on sec.gov)
AllianceBernstein LP55,792$342kunder 0.1%Added+32,70014 Aug 2026 (the filing on sec.gov)
Man Group PLC24,208$240kunder 0.1%Trimmed-84,90914 Aug 2026 (the filing on sec.gov)
Walleye Capital LLC19,066$189kunder 0.1%Newnew3 Aug 2026 (the filing on sec.gov)
Squarepoint Ops LLC15,689$155kunder 0.1%Trimmed-39,24114 Aug 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP14,969$148kunder 0.1%Trimmed-50,79414 Aug 2026 (the filing on sec.gov)
Janus Henderson Group Ltd14,534$144kunder 0.1%Held014 Aug 2026 (the filing on sec.gov)
Fidelity (FMR LLC)6,951$69kunder 0.1%Added+4,93913 Aug 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

0246Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
DNA by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20245$62m50
Q4 20244$72m13
Q1 20254$43m11
Q2 20254$80m03
Q3 20255$104m12
Q4 20254$52m167
Q1 20262$37m916
Q2 20263$61m1110

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

DNA and GILD →DNA and AMGN →DNA and ARGX →Choose a stock to compare with DNA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own DNA, latest filings →Back to the 13F Explorer →